Clinical Trial Update: Benefit of Early Protocol Biopsy and Treatment of Subclinical Rejection [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update assessing the benefit of early protocol biopsy and treatment of subclinical rejection in kidney transplant patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Kidney Transplantation | Phase 4 | Status: COMPLETED